JP2018512454A5 - - Google Patents

Download PDF

Info

Publication number
JP2018512454A5
JP2018512454A5 JP2018502035A JP2018502035A JP2018512454A5 JP 2018512454 A5 JP2018512454 A5 JP 2018512454A5 JP 2018502035 A JP2018502035 A JP 2018502035A JP 2018502035 A JP2018502035 A JP 2018502035A JP 2018512454 A5 JP2018512454 A5 JP 2018512454A5
Authority
JP
Japan
Prior art keywords
antimicrobial
amino acid
composition according
seq
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018502035A
Other languages
English (en)
Japanese (ja)
Other versions
JP6964577B2 (ja
JP2018512454A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/023801 external-priority patent/WO2016154328A2/en
Publication of JP2018512454A publication Critical patent/JP2018512454A/ja
Publication of JP2018512454A5 publication Critical patent/JP2018512454A5/ja
Application granted granted Critical
Publication of JP6964577B2 publication Critical patent/JP6964577B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018502035A 2015-03-23 2016-03-23 抗菌性ペプチド及びその使用方法 Active JP6964577B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562137206P 2015-03-23 2015-03-23
US62/137,206 2015-03-23
PCT/US2016/023801 WO2016154328A2 (en) 2015-03-23 2016-03-23 Antimicrobial peptides and methods of use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020207711A Division JP7267251B2 (ja) 2015-03-23 2020-12-15 抗菌組成物及び医薬組成物

Publications (3)

Publication Number Publication Date
JP2018512454A JP2018512454A (ja) 2018-05-17
JP2018512454A5 true JP2018512454A5 (https=) 2019-05-09
JP6964577B2 JP6964577B2 (ja) 2021-11-10

Family

ID=56978879

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018502035A Active JP6964577B2 (ja) 2015-03-23 2016-03-23 抗菌性ペプチド及びその使用方法
JP2020207711A Active JP7267251B2 (ja) 2015-03-23 2020-12-15 抗菌組成物及び医薬組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020207711A Active JP7267251B2 (ja) 2015-03-23 2020-12-15 抗菌組成物及び医薬組成物

Country Status (8)

Country Link
US (2) US10017542B2 (https=)
EP (2) EP3903823A3 (https=)
JP (2) JP6964577B2 (https=)
KR (1) KR20180002618A (https=)
CN (2) CN107614004B (https=)
AU (2) AU2016235147B2 (https=)
CA (1) CA2981705A1 (https=)
WO (1) WO2016154328A2 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10017542B2 (en) * 2015-03-23 2018-07-10 Riptide Bioscience, Inc. Antimicrobial peptides and methods of use thereof
US20200131231A1 (en) 2017-02-17 2020-04-30 Oxford University Innovation Limited Cell penetrating peptides
GB201812972D0 (en) 2018-08-09 2018-09-26 Univ Oxford Innovation Ltd Cell-penetrating peptides
GB201812980D0 (en) 2018-08-09 2018-09-26 Univ Oxford Innovation Ltd Cell-penetrating peptides
CA3110618A1 (en) * 2018-08-29 2020-03-05 Riptide Bioscience, Inc. Peptides having immunomodulatory properties
US10413584B1 (en) 2018-08-29 2019-09-17 Riptide Bioscience, Inc. Peptides having immunomodulatory properties
US20200102356A1 (en) * 2018-10-01 2020-04-02 NMC Inc. Compositions and Methods for the Treatment of Huanglongbing (HLB) aka Citrus Greening in Citrus Plants
JP7755994B2 (ja) * 2018-10-19 2025-10-17 リップタイド バイオサイエンス インコーポレイテッド 抗菌性ペプチド及びその使用方法
US10548944B1 (en) * 2018-10-19 2020-02-04 Riptide Bioscience, Inc. Antimicrobial peptides and methods of using the same
US12465646B2 (en) 2018-12-07 2025-11-11 Oxford University Innovation Limited Linkers
US12509414B2 (en) * 2019-04-04 2025-12-30 National Taiwan Ocean University Carbon quantum dot, a composition thereof and a method for treating infection by using same
KR20210151945A (ko) 2019-04-12 2021-12-14 립타이드 바이오사이언스, 인코포레이티드 대식세포 활성을 조정하기 위한 방법
CN110305193B (zh) * 2019-07-18 2021-10-08 河南科技大学 一种抗牙龈卟啉单胞菌多肽及应用
AU2021246017A1 (en) * 2020-03-31 2022-11-10 Innate Immunity LLC Recombinant peptide to treat fire blight
US20240287135A1 (en) * 2021-09-03 2024-08-29 Qc Bio-Technology (Shenzhen) Co., Ltd. Antimicrobial peptide or peptide derivative, substitute, and composition thereof, and preparation method and application of composition
CN114989254B (zh) * 2022-06-17 2023-11-03 中山大学 一种多肽及其设计方法和在制备抑制具核梭杆菌产品或预防结直肠癌药物中的应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL90356A0 (en) * 1988-05-27 1989-12-15 Magainin Sciences Inc Amphiphilic peptides and pharmaceutical compositions containing them
CA2032527C (en) * 1989-04-10 2002-07-02 Jesse M. Jaynes Lytic peptides: their use in the treatment of microbial infections, cancer and in the promotion of growth
US5561107A (en) * 1993-06-04 1996-10-01 Demeter Biotechnologies, Ltd. Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides
IL114697A0 (en) * 1994-07-22 1995-11-27 Demeter Biotech Ltd Polypeptides comprising ubiquitin-lytic peptide fusion protein products deriving therefrom their preparation and use
JPH08134075A (ja) * 1994-11-02 1996-05-28 Yamanouchi Pharmaceut Co Ltd 新規なカルバペネム誘導体
CA2242660A1 (en) * 1996-02-16 1997-08-21 The Regents Of The University Of California Antimicrobial peptides and methods of use
JP2001501620A (ja) * 1996-10-04 2001-02-06 デメジェン インコーポレイテッド 免疫不全ウイルス感染の治療方法
US6680058B1 (en) * 1997-09-03 2004-01-20 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Compositions and methods for contraception in or sterilization of mammals
IL146743A0 (en) * 1999-05-31 2002-07-25 Novozymes As Screening method for peptides
US6432415B1 (en) * 1999-12-17 2002-08-13 Axrix Laboratories, Inc. Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces
AU2003269851A1 (en) * 2002-10-09 2004-05-04 Novozymes A/S A method for screening for an antimicrobial polypeptide
KR101413746B1 (ko) * 2005-12-22 2014-07-01 노바바이오틱스 리미티드 고리형 항균 펩타이드
NZ571989A (en) * 2006-03-23 2012-07-27 Agriculture Victoria Serv Pty Antimicrobial protein
CN101448851B (zh) * 2006-05-16 2013-11-06 佩加马公司 改进的抗微生物肽
US7288622B1 (en) * 2006-09-19 2007-10-30 Issar Pharmaceuticals Pvt Ltd Composition for treatment of burns and wounds
US7803755B2 (en) * 2006-12-21 2010-09-28 Jesse Jaynes Molecules for the treatment and prevention of fungal diseases
US9163066B2 (en) * 2010-06-29 2015-10-20 Agromed Llc Antimicrobial lytic peptides
EP2468856A1 (en) * 2010-12-23 2012-06-27 Lysando Aktiengesellschaft Antimicrobial Agents
US10017542B2 (en) * 2015-03-23 2018-07-10 Riptide Bioscience, Inc. Antimicrobial peptides and methods of use thereof

Similar Documents

Publication Publication Date Title
JP2018512454A5 (https=)
JP7668793B2 (ja) 抗菌オルガノシラン
CN102906105B (zh) 肽及其用途
JP6964577B2 (ja) 抗菌性ペプチド及びその使用方法
JP2019073561A5 (https=)
JP2022513223A5 (https=)
JP2012522037A5 (https=)
CN102872447A (zh) 抗微生物肽，组合物和使用方法
JP2014518849A5 (https=)
JP2017526627A5 (https=)
JPWO2019156137A5 (https=)
JP2016535781A5 (https=)
JP2009526045A (ja) 新規抗菌ペプチド及びその使用
JP2017525676A5 (https=)
JP2013509389A5 (https=)
FI3294345T3 (fi) Tpp1-formulaatioita ja menetelmiä cln2-taudin hoitamiseksi
RU2012131251A (ru) Композиции и способы для лечения связанных с ангиогенезом заболеваний глаз
JP2010536714A5 (https=)
CN101641370A (zh) 碱性肽及其作为联合抗细菌-抗真菌剂的用途
JP2023537951A5 (https=)
US20160106689A1 (en) Use
WO2016046523A1 (en) Use of cystamine for treating bacterial and fungal infections
CN110799522A (zh) 用于治疗、改善或预防脑出血的肽及其用途
JP2020513033A5 (https=)
SE2151338A1 (en) Truncated peptides